central nervous system

Evidence for Sustained Elevation of IL-6 in the CNS as a Key Contributor of Depressive-Like Phenotypes.

Published December 7, 2012

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

Filed under: Depression Treatment

Transl Psychiatry. 2012; 2: e199
Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, Brandon… Continue reading →

Depression Treatment: Importance of the Brain Angiotensin System in Parkinson’s Disease.

Published December 6, 2012

Importance of the brain Angiotensin system in Parkinson’s disease.

Filed under: Depression Treatment

Parkinsons Dis. 2012; 2012: 860923
Wright JW, Harding JW

Parkinson’s disease (PD) has become a major health problem affecting 1.5% of the world’s population over 65… Continue reading →

Neuromodulation: A More Comprehensive Concept Beyond Deep Brain Stimulation.

Published December 5, 2012

Neuromodulation: a more comprehensive concept beyond deep brain stimulation.

Filed under: Addiction Rehab

Int Rev Neurobiol. 2012; 107: 1-3
Hamani C, Moro E

As currently understood, neuromodulation comprises not only electrical and magnetic stimulation but also chemical and genetic… Continue reading →

Addiction Rehab: Project ECHO: A Model for Complex, Chronic Care in the Pacific Northwest Region of the United States.

Published December 5, 2012

Project ECHO: a model for complex, chronic care in the Pacific Northwest region of the United States.

Filed under: Addiction Rehab

J Telemed Telecare. 2012 Dec 3;
Scott JD, Unruh KT, Catlin MC, Merrill JO, Tauben DJ, Rosenblatt R,… Continue reading →

Cytochrome P450-Mediated Drug Metabolism in the Brain.

Published December 4, 2012

Cytochrome P450-mediated drug metabolism in the brain.

Filed under: Addiction Rehab

J Psychiatry Neurosci. 2012 Dec 4; 37(6): 120133
Miksys S, Tyndale RF

Cytochrome P450 enzymes (CYPs) metabolize many drugs that act on the central nervous system (CNS), such… Continue reading →

ABCB1 Polymorphism Predicts Escitalopram Dose Needed for Remission in Major Depression.

Published November 29, 2012

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.

Filed under: Depression Treatment

Transl Psychiatry. 2012; 2: e198
Singh AB, Bousman CA, Ng CH, Byron K, Berk M

The ATP-binding cassette family of transporter proteins, subfamily B… Continue reading →

Depression Treatment: Cognitive Functioning in Pediatric Transverse Myelitis.

Published November 21, 2012

Cognitive functioning in pediatric transverse myelitis.

Filed under: Depression Treatment

Mult Scler. 2012 Nov 19;
Harder LL, Holland AA, Frohman E, Graves D, Greenberg BM

BACKGROUND: Transverse myelitis (TM) is an inflammatory disease of the spinal cord. In pediatric… Continue reading →

Depression Treatment: Lifestyle-Oriented Non-Pharmacological Treatments for Fibromyalgia: A Clinical Overview and Applications With Home-Based Technologies.

Published November 21, 2012

Lifestyle-oriented non-pharmacological treatments for fibromyalgia: a clinical overview and applications with home-based technologies.

Filed under: Depression Treatment

J Pain Res. 2012; 5: 425-35
Friedberg F, Williams DA, Collinge W

Fibromyalgia (FM) is a persistent and disabling widespread pain condition… Continue reading →

Neurobiological Basis of Dyskinetic Effects Induced by Antipsychotics: The Contribution of Animal Models.

Published November 21, 2012

Neurobiological basis of dyskinetic effects induced by antipsychotics: the contribution of animal models.

Filed under: Addiction Rehab

Curr Med Chem. 2012 Nov 13;
Creed MC, Nobrega JN

Tardive dyskinesia (TD) is a movement disorder characterized by abnormal involuntary facial… Continue reading →

Cognitive Treatment of Illness Perceptions in Patients With Chronic Low Back Pain: A Randomized Controlled Trial.

Published November 20, 2012

Cognitive Treatment of Illness Perceptions in Patients With Chronic Low Back Pain: A Randomized Controlled Trial.

Filed under: Rehab Centers

Phys Ther. 2012 Nov 15;
Siemonsma PC, Stuive I, Roorda LD, Vollebregt JA, Walker MF, Lankhorst GJ, Lettinga AT… Continue reading →

Evidence for Sustained Elevation of IL-6 in the CNS as a Key Contributor of Depressive-Like Phenotypes.

Depression Treatment: Importance of the Brain Angiotensin System in Parkinson’s Disease.

Neuromodulation: A More Comprehensive Concept Beyond Deep Brain Stimulation.

Addiction Rehab: Project ECHO: A Model for Complex, Chronic Care in the Pacific Northwest Region of the United States.

Cytochrome P450-Mediated Drug Metabolism in the Brain.

ABCB1 Polymorphism Predicts Escitalopram Dose Needed for Remission in Major Depression.

Neurobiological Basis of Dyskinetic Effects Induced by Antipsychotics: The Contribution of Animal Models.

Cognitive Treatment of Illness Perceptions in Patients With Chronic Low Back Pain: A Randomized Controlled Trial.

Recent Posts

Search this Site